Erythropoietin administration

DRUG2 trials

Sponsors

Medical College of Wisconsin, UMC Utrecht

Conditions

Heart Failure, CongestiveRenal Insufficiency, ChronicTraumatic Brain Injury

Phase 2

Erythropoietin Effects After Traumatic Brain Injury

WithdrawnNCT00260052

Medical College of WisconsinTraumatic Brain Injury

Start: 2003-07-31End: 2010-01-31Updated: 2015-08-24

Phase 3

Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome

CompletedNCT00356733

UMC UtrechtHeart Failure, Congestive, Renal Insufficiency, Chronic

Start: 2007-01-31End: 2011-07-31Updated: 2011-12-02

Related Papers

Epoetin Beta and C-Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease.

2019-08-1718 citations

Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment.

2012-12-1215 citations

Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging.

2012-09-188 citations